Table 3.
Requirement | Female of reproductive potential | Pre-pubertal | Post-menopausal or other medical reasons for permanent irreversible infertility |
---|---|---|---|
Prescriber enrolls female patients into the riociguat (Adempas) REMS program | X | X | X |
Counseling with the Adempas REMS Guide for Females Who Can Get Pregnant | X | ||
Counseling with the Riociguat (Adempas) Medication Guide, including the risk of teratogenicity | X | X | |
Prescriber must order and review pregnancy tests before starting treatment, monthly during treatment, and for 1 month after stopping treatment | X | ||
Prescriber must verify reproductive status annually by completing the “Riociguat (Adempas) REMS Change in Reproductive Potential Status and Pre-pubertal Annual Verification Form” for females who are at least 8 years of age | X | ||
Prescriber must complete the “Riociguat (Adempas) REMS Change in Reproductive Potential Status and Pre-pubertal Annual Verification Form” upon becoming aware of any changes or misclassification in reproductive status | X | X | X |
Abbreviation: REMS, risk evaluation and mitigation strategy.
Source: Adempas [package insert]. Whippany, NJ: Bayer HealthCare Pharmaceuticals Inc; 2018. 43